These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4715005)

  • 1. Folic acid analogs. Modifications in the benzene-ring region. 3. Neohomofolic and neobishomofolic acids. An improved synthesis of folic acid and its analogs.
    Roberts EC; Shealy YF
    J Med Chem; 1973 Jun; 16(6):697-9. PubMed ID: 4715005
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid analogs. Modifications in the benzene-ring region. 2. Thiazole analogs.
    Roberts EC; Shealy YF
    J Med Chem; 1972 Dec; 15(12):1310-2. PubMed ID: 4629013
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid analogs. Modifications in the benzene-ring region. 4. 3'-Ethyl- and 3'-isopropylfolic acids.
    Roberts EC; Shealy YF
    J Med Chem; 1974 Feb; 17(2):219-22. PubMed ID: 4203367
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1-deaza-N10-methylfolic acid and related compounds.
    Elliott RD; Temple C; Montgomery JA
    J Med Chem; 1974 May; 17(5):553-5. PubMed ID: 4208481
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of quinazoline analogs of isofolic acid.
    Hynes JB; Garrett CM
    J Med Chem; 1975 Jun; 18(6):632-4. PubMed ID: 1151982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential folic acid antagonists. 5. Synthesis and biologic evaluation of N 10 -deazapteroic acid and N 10 -deazafolic acid and their 9,10-dehydro derivatives.
    Struck RF; Shealy YF; Montgomery JA
    J Med Chem; 1971 Aug; 14(8):693-8. PubMed ID: 5000360
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin.
    Taylor EC; Harrington PJ; Fletcher SR; Beardsley GP; Moran RG
    J Med Chem; 1985 Jul; 28(7):914-21. PubMed ID: 4009615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
    Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CXXXV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(p-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):79-81. PubMed ID: 5763045
    [No Abstract]   [Full Text] [Related]  

  • 11. Sycnthesis of quinazoline analogues of folic acid modified at postion 10.
    Oatis JE; Hynes JB
    J Med Chem; 1977 Nov; 20(11):1393-6. PubMed ID: 915899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
    [No Abstract]   [Full Text] [Related]  

  • 13. Folic acid analogs. II. p-[(2,6-Diamino-8-purinyl)methyl]amino-benzoyl-L-glutamic acid and related compounds.
    Weinstock LT; Grabowski BF; Cheng CC
    J Med Chem; 1970 Sep; 13(5):995-7. PubMed ID: 5458404
    [No Abstract]   [Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):74-8. PubMed ID: 5763044
    [No Abstract]   [Full Text] [Related]  

  • 16. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrimido(5,4-e)-as-triazines. VII. Synthesis of 7-aza analogs of pteroic and folic acids.
    Temple C; Kussner CL; Montgomery JA
    J Org Chem; 1974 Sep; 39(19):2866-71. PubMed ID: 4415410
    [No Abstract]   [Full Text] [Related]  

  • 18. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
    Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
    J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts.
    Hynes JB; Patil SA; Hagan RL; Cole A; Kohler W; Freisheim JH
    J Med Chem; 1989 Apr; 32(4):852-6. PubMed ID: 2704031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogues of methotrexate.
    Montgomery JA; Piper JR; Elliott RD; Temple C; Roberts EC; Shealy YF
    J Med Chem; 1979 Jul; 22(7):862-8. PubMed ID: 448685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.